Observational studyInternational journal of clinical pharmacy2026
Comparison of existing polypharmacy measures to a measure incorporating all modes of administration: an observational study using routinely collected data.
Observational study in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPolypharmacy is often associated with adverse clinical outcomes and increased medication management complexity. However conventional analyses of medicine burden and polypharmacy using administrative data are limited to oral medicines (i.e. tablets and capsules), potentially underestimating overall medicine exposure. These products may significantly increase the burden of medication management and therefore risk to patients.
aimThis study compared traditional measures of polypharmacy with a measure incorporating all modes of medicine administration and examined how these differences impacted estimates of polypharmacy prevalence among adults aged > 65 years in Western Australia (WA) from 2012/13 to 2018/19, between two independent cohorts: community-dwelling and residential aged care home populations.
methodLinked medication dispensing data were used to classify and compare medicines between community-dwelling and residential aged care populations in Western Australia. Conventional medicine capture was extended to include medicines via various modes of administration, including creams, ointments, patches, and eye and ear drops. Medicines were classified into five categories: 0, 1, 2-4, 5-8, 9 + medicines, and counts were compared across care settings to assess changes in observed medicine burden and measures of polypharmacy. Comparative analysis was performed between two methods: Method 1 (conventional medicine capture) and Method 2 (all medicines including non-oral preparations).
resultsInclusion of medicines via mode of administration increased observed medicine burden in both subpopulations, with a greater relative increase in residential aged care. This approach notably contributed to total medicine counts, revealing previously unrecognised medicine exposure. This resulted in absolute increases in the 5 + medicine category of 4.0% in 2012/13 and 3.4% in 2018/19. Among aged care residents, opioid analgesics previously ranked as the most common medicine class using Method 1, was reclassified as separate oral and patch formulations using Method 2, ranking 4th and 5th. Drugs for dry eyes also emerged as the 7th most common medicine class, with only minor ranking changes observed for the other top medicine classes.
conclusionIncorporating all modes of medicine administration into a polypharmacy measure substantially altered estimates of medicine burden and identified previously unrecognised exposure, particularly among residential aged care populations. The impact was greatest in higher polypharmacy categories, indicating that conventional approaches may underestimate medicine use in individuals with more complex therapeutic regimens. These findings highlight the importance of accounting for formulation diversity and support the inclusion of mode-of-administration-based measures to provide a more comprehensive assessment of medication exposure and complexity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.